This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

IBM, Janus: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.


Affiliated Managers (AMG) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock is already pricing in higher asset flows.

Apollo (APOL) rated new Buy at Goldman. $54 price target. New enrollment declines should begin to stabilize by the August quarter.

Blackstone (BX) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company was also removed from the Conviction List. Valuation call.

Carefusion (CFN) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $30 price target.

Columbia Sportswear (COLM) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $70 price target. Sales outlook remains strong.

Dr. Pepper Snapple (DPS) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $37 price target. Company is facing higher commodity costs.

Education Management (EDMC) downgraded at Goldman to Sell from Neutral, Goldman Sachs said. $18 price target. Company is most exposed to new regulations.

Energizer (ENR) downgraded at UBS from Buy to Neutral, UBS said. $76 price target. Focus on Hydro razor could hurt other divisions.

Ensco (ESV) upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. $75 price target. Stock is pricing in the recent ban in the Gulf of Mexico.

Hershey (HSY - Get Report) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Price increases should help drive earnings growth. $59 price target.

IBM (IBM - Get Report) downgraded at Canaccord from Buy to Hold, Canaccord Genuity said. Valuation call, based on a $180 price target.

Jack in the Box (JACK - Get Report) downgraded at Credit Suisse to Underperform from Neutral. Overpaying for a post-refranchising business, Credit Suisse said. Price target lowered by a dollar to $20.

Janus (JNS - Get Report) upgraded at Wells from Market Perform to Outperform. Net outflows should begin to decelerate.

Medtronic (MDT - Get Report) upgraded at Wells from Market Perform to Outperform. Growth is accelerating.

Magellan Health (MGLN - Get Report) rated new Underperform at BofA/Merrill. $50 price target. Organic growth will likely lag peers.

Monsanto (MON) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Valuation call, based on a $78 price target.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
JACK $96.72 -1.50%
JNS $16.47 -1.30%
HSY $103.80 0.16%
IBM $161.98 0.69%
MDT $77.60 -1.50%


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs